Turkish Health Minister Fahrettin Koca said at a news conference on Thursday that the CoronaVac vaccine developed by China's Sinovac Biotech has 91.25 percent efficacy.

Turkish researchers said no major side-effects were seen during trials, adding that the efficacy level is likely to increase in later assessments.

Koca said three million doses of the vaccine will arrive in Turkey on December 28.